Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-SPECT ESUS Japan: Dabigatran vs Aspirin in Embolic Stroke of Undetermined Source
jRCT2080222816Phase 3Completed
- Start
- Apr 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of dabigatran in embolic stroke of undetermined source (ESUS) and ischemic stroke (2 arms). Primary endpoint: Recurrent stroke. Started Apr 2015; status: completed.
02
Drugs
dabigatran
03
Conditions
embolic stroke of undetermined source (ESUS)ischemic stroke
Beyond the preview
Go deeper on jRCT2080222816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222816.